Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 1,070.00p on 27-02-2026 at 19:40:06
Change 5.00p 0.45%
Buy 1,135.00p
Sell 1,080.00p
Last Trade: Sell 7.00 at 1,100.2666p
Day's Volume: 14,301
Last Close: 1,107.50p
Open: 1,075.00p
ISIN: GB00BQVXM815
Day's Range 1,055.00p - 1,170.00p
52wk Range: 124.50p - 1,790.00p
Market Capitalisation: £68.21m
VWAP: 1,108.89393p
Shares in Issue: 6.37m

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 7 1,100.2666p Ordinary
16:24:50 - 27-Feb-26
Buy* 187 1,135.00p SI Trade
16:19:17 - 27-Feb-26
Buy* 1 1,135.00p SI Trade
16:17:00 - 27-Feb-26
Sell* 3 1,100.2666p Ordinary
16:05:22 - 27-Feb-26
Sell* 5 1,070.2925p Ordinary
16:01:19 - 27-Feb-26
Buy* 540 1,134.60p Ordinary
16:00:56 - 27-Feb-26
Buy* 500 1,130.2344p Ordinary
15:59:41 - 27-Feb-26
Sell* 500 1,099.25p Ordinary
15:56:12 - 27-Feb-26
Buy* 14 1,135.00p SI Trade
15:55:00 - 27-Feb-26
Sell* 2 1,070.00p SI Trade
15:51:39 - 27-Feb-26
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Feb 2026 (Fri) 1,075.00 1,170.00 1,055.00 1,107.50 14,301
26th Feb 2026 (Thu) 1,000.00 1,220.00 1,000.00 1,102.50 28,177
25th Feb 2026 (Wed) 1,085.00 1,205.00 1,085.00 1,080.00 32,369
24th Feb 2026 (Tue) 1,120.00 1,200.00 1,100.00 1,140.00 36,053
23rd Feb 2026 (Mon) 980.00 1,090.00 980.00 1,046.00 32,533
20th Feb 2026 (Fri) 924.00 1,030.00 910.00 999.00 28,478
19th Feb 2026 (Thu) 1,015.00 1,015.00 926.00 961.00 11,997
18th Feb 2026 (Wed) 896.00 1,020.00 850.00 964.00 49,982
17th Feb 2026 (Tue) 926.00 926.00 862.00 892.00 13,213
16th Feb 2026 (Mon) 956.00 960.00 930.00 926.00 14,506
13th Feb 2026 (Fri) 900.00 948.00 874.00 919.00 10,906
12th Feb 2026 (Thu) 850.00 940.00 848.00 930.00 14,190
11th Feb 2026 (Wed) 906.00 978.00 850.00 906.00 15,048
10th Feb 2026 (Tue) 848.00 1,100.00 796.00 952.00 109,206
9th Feb 2026 (Mon) 1,155.00 1,160.00 860.00 915.00 73,083
6th Feb 2026 (Fri) 992.00 1,145.00 992.00 1,100.00 92,868
5th Feb 2026 (Thu) 900.00 992.00 820.00 992.00 91,711
4th Feb 2026 (Wed) 830.00 880.00 810.00 842.00 29,074
3rd Feb 2026 (Tue) 732.00 830.00 732.00 800.00 24,765
2nd Feb 2026 (Mon) 732.00 842.00 702.00 740.00 47,235
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
27th Feb 2026 8:10 am RNS Total Voting Rights
24th Feb 2026 7:00 am RNS Holding(s) in Company
23rd Feb 2026 7:00 am RNS Exercise of Warrants and Issue of Equity
10th Feb 2026 3:52 pm RNS Issue of Equity - Correction
10th Feb 2026 7:00 am RNS Issue of Equity
30th Jan 2026 7:00 am RNS Total Voting Rights
12th Jan 2026 7:00 am RNS Holding(s) in Company
22nd Dec 2025 8:00 am RNS Update on Admission of Shares
18th Dec 2025 7:00 am RNS Issue of Equity
8th Dec 2025 12:48 pm RNS Holding(s) in Company
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

EARNINGS AND TRADING: Asia Strategic "well-positioned" as loss narrows

10th Feb 2026 19:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

LONDON MARKET MIDDAY: FTSE 100 dips as banks slide, mid-caps rise

10th Feb 2026 12:12

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with the FTSE 100 edging lower as investors weighed a busy flow of company news while mid-cap stocks held up better. Read More

SMALL-CAP WINNERS & LOSERS: Hemogenyx raises funds for phase I trials

10th Feb 2026 10:46

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value10,910.55
Change63.85

Login to your account

Forgot Password?

Not Registered